Skip to main content

Table 3 Study arms

From: A double blind randomised controlled trial comparing standard dose of iron supplementation for pregnant women with two screen-and-treat approaches using hepcidin as a biomarker for ready and safe to receive iron

Group

Dose (mg/day Fe)

Universal (N)

Screen with Hepcidin (Yes or No)

A

60

154

No

Ba

60

154

Yes

Ca

30

154

Yes

  1. aGroups B and C will be tested weekly and only given their next seven day supply of iron if plasma hepcidin falls below cut-off for ‘safe and ready’